Study of the effect of bread containing flaxseed on patients with metabolic syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180305038966N2

Enrollment

Registered

2018-08-18

Start date

2018-07-16

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome.

Interventions

Intervention 1: Intervention group: intake 2 unit of bread containing 20 gram of flax seed flour and 80 gram of wheat flour for 6 weeks and twice a day. Intervention 2: Control group: intake 2 unit of

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Having 3 Indices of 5 Metabolic Syndrome Indicators. Waist circumference is more than 102 centimeters for men and more than 88 centimeters for women. The level of triglyceride is greater than or equal to 150 mg / dL. HDL cholesterol levels less than 40 for men and less than 50 mg per decilitre for women. The fasting blood sugar level is greater than or equal to 100 mg / dL. The blood pressure is greater than or equal to 130/85 mmHg Men and wemen 20-50 years old Patients who agree to participate in the study

Exclusion criteria

Exclusion criteria: Tobacco use - Adherence to a particular diet - Consumption bread of flaxseed in the last 6 months - Pregnancy, breast feeding, menopause

Design outcomes

Primary

Measure	Time frame
Serum level of triglyceride. Timepoint: At the beginning of the study and the end of the sixth week. Method of measurement: By enzyme- mg/dl.;Serum level of HDL. Timepoint: At the beginning of the study and the end of the sixth week. Method of measurement: By enzyme- mg/dl.;Serum level of FBS. Timepoint: At the beginning of the study and the end of the sixth week. Method of measurement: By enzyme- mg/dl.;Blood pressure. Timepoint: At the beginning of the study and the end of the sixth week. Method of measurement: Digital Manometer mmHg.;Waist. Timepoint: At the beginning of the study and the end of the sixth week. Method of measurement: Strip Meter- Centimeters.;Body mass index. Timepoint: At the beginning of the study and the end of the sixth week. Method of measurement: Formula weight/ High2.;Physical activity. Timepoint: Initially,the middle and end of the sixth week study. Method of measurement: Met questionnaire.;Food intake. Timepoint: Initially,the middle and end of the sixth week study. Method of measurement: Food frequency questionnaire 3 days.	—

Measure

Time frame

Serum level of triglyceride. Timepoint: At the beginning of the study and the end of the sixth week. Method of measurement: By enzyme- mg/dl.;Serum level of HDL. Timepoint: At the beginning of the study and the end of the sixth week. Method of measurement: By enzyme- mg/dl.;Serum level of FBS. Timepoint: At the beginning of the study and the end of the sixth week. Method of measurement: By enzyme- mg/dl.;Blood pressure. Timepoint: At the beginning of the study and the end of the sixth week. Method of measurement: Digital Manometer mmHg.;Waist. Timepoint: At the beginning of the study and the end of the sixth week. Method of measurement: Strip Meter- Centimeters.;Body mass index. Timepoint: At the beginning of the study and the end of the sixth week. Method of measurement: Formula weight/ High2.;Physical activity. Timepoint: Initially,the middle and end of the sixth week study. Method of measurement: Met questionnaire.;Food intake. Timepoint: Initially,the middle and end of the sixth week study. Method of measurement: Food frequency questionnaire 3 days.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNahid Shakeri

Islamic Azad University

nutrition@mail.mui.ac.ir+98 31 3233 0091

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026